It allows patients to provide health data using products they’re already familiar with in a protected manner, without the expense, time and potential contact with other diseases that needless clinical appointments might entail. Furthermore to monitoring, TeleHealth Manager provides reminders, alerts and online reports to help patients and their healthcare professionals better understand and manage their conditions. Related StoriesHealthcare technology social event of the year opens entriesUsing integrated molecular pathology to control incidental pancreatic cysts: an interview with Dr Ananya DasSurgical startup seeks financing to build virtual reality teaching libraryFaced with issues such as an aging human population and rising healthcare costs, hospitals and doctors are increasingly embracing innovative communications technology such as remote individual monitoring to health supplement face-to-face care.ARIAD’s income for the three and six-month periods finished June 30, 2011 of $66,000 and $122,000, respectively, represent a decrease of $175.0 million and $177.1 million from revenues recorded in the comparable intervals in 2010 2010, primarily due to the influence of the Merck restructuring. ARIAD reported operating expenditures of $24.june 30 9 million for the three-month period ended, 2011, a rise of $7.1 million over the comparable period this year 2010, and operating expenses of $44.3 million for the six-month period ended June 30, 2011, also an increase of $7.1 million over the comparable period in 2010 2010. These raises reflect primarily the continued advancement of ARIAD’s product candidates, ponatinib and AP26113, expenditures for corporate and industrial development initiatives, and increases in stock-based compensation because of the influence of the increased share price on the worthiness of stock-based compensation awards.